h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases

H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC

(2015) Marianeve Carotenuto et al.   Oncotarget

Co-Overexpression of GEP100 and AMAP1 Proteins Correlates with Rapid Local Recurrence after Breast Conservative Therapy

(2013) Rumiko Kinoshita et al.   PLoS One

Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases

(2013) Arpad Ivanecz et al.   HPB

EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness

(2012) Ester Sánchez-Tilló et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Novel pyrimidopyrimidine derivatives for inhibition of cellular proliferation and motility induced by h-prune in breast cancer

(2012) Antonella Virgilio et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial–mesenchymal transition

(2012) Rongzhi Zhao et al.   EXPERIMENTAL CELL RESEARCH

BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy

(2012) Hao-Wei Teng et al.   JOURNAL OF SURGICAL ONCOLOGY

Rho inhibitor prevents ischemia–reperfusion injury in rat steatotic liver

(2011) Shintaro Kuroda et al.   JOURNAL OF HEPATOLOGY

Surgical management and outcomes of colorectal cancer liver metastases

(2010) E. J. A. Morris et al.   BRITISH JOURNAL OF SURGERY

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance

(2010) Zhiwei Wang et al.   DRUG RESISTANCE UPDATES

ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo and correlates with poor survival in colorectal cancer patients

(2010) T Müller et al.   ONCOGENE

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase

(2010) H Yamamoto et al.   ONCOGENE

Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

(2009) Myrddin Rees et al.   ANNALS OF SURGERY

KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases

(2009) Garrett M. Nash et al.   ANNALS OF SURGICAL ONCOLOGY

Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases

(2009) M. D. Smith et al.   BRITISH JOURNAL OF SURGERY

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease

(2009) Hervé Acloque et al.   JOURNAL OF CLINICAL INVESTIGATION

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Liver Surgery for Colorectal Metastases: Results after 10 Years of Follow-Up. Long-Term Survivors, Late Recurrences, and Prognostic Role of Morbidity

(2008) Luca Viganò et al.   ANNALS OF SURGICAL ONCOLOGY

Human Metastasis Regulator Protein H-Prune is a Short-Chain Exopolyphosphatase†

(2008) Marko Tammenkoski et al.   BIOCHEMISTRY

Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells

(2008) B. C. Fuchs et al.   CANCER RESEARCH

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers

(2008) Michèle Sabbah et al.   DRUG RESISTANCE UPDATES